Cloud-clone
SKU:PAB817Hu01
Polyclonal Antibody to Versican (VCAN)
Polyclonal Antibody to Versican (VCAN)
Couldn't load pickup availability
;Immunohistochemistry: 5-50µg/mL;
;Immunocytochemistry: 5-50µg/mL;
;Optimal working dilutions must be determined by end user.
Product No.
PAB817Hu01
Organism Species
Homo sapiens (Human).
Source
Polyclonal antibody preparation
Host
Rabbit
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
RPB817Hu01-Recombinant Versican (VCAN)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
0.5mg/ml
Organism Species More
n/a
Applications
WB,IHC
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against VCAN. It has been selected for its ability to recognize VCAN in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.01-5µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Plos one | Tumor-Produced Versican V1 Enhances hCAP18/LL-37 Expression in Macrophages through Activation of TLR2 and Vitamin D3 Signaling to Promote Ovarian Cancer Progression In Vitro PubMed: PMC3570526 |
| Clinica Chimica Acta | Versican and its associated molecules: Potential diagnostic markers for multiple myeloma Pubmed:25623955 |
| Journal of Cancer Research and Clinical Oncology | Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma |
| RNA Biology | Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signaling Pubmed: 31532704 |
| miR-124-3p and miR-181a-5p Mediate AT1-Receptor Autoantibody Induced Fetal Rat Cardiac Remodeling via Increased VCAN Expression |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPB817Hu02 | Recombinant Versican (VCAN) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB817Hu01 | Recombinant Versican (VCAN) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB817Hu01 | Polyclonal Antibody to Versican (VCAN) | WB,IHC |
| PAB817Hu02 | Polyclonal Antibody to Versican (VCAN) | WB; IHC; ICC; IP. |
| MAB817Hu22 | Monoclonal Antibody to Versican (VCAN) | WB; IHC; ICC; IP. |
| SEB817Hu | ELISA Kit for Versican (VCAN) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCB817Hu | CLIA Kit for Versican (VCAN) | Chemiluminescent immunoassay for Antigen Detection. |
| LMB817Hu | Magnetic Luminex Assay Kit for Versican (VCAN) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
